Germany· DE-A57-cca718a90146baa4
Oxytocin Hexal
A oxytocin product containing oxytocin, registered in Germany by Hexal Ag. The same ATC class is registered in 16 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Oxytocin is registered in 16 of 19 countries.
Countries holding a registration under ATC H01BB02 (oxytocin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 9 of them publish a price we can compare per daily dose
Oxytocin · ATC H01BB02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Oxytocin
- Manufacturer
- Hexal Ag
- Country
- Germany (DE)
- ATC code
- H01BB02
- ATC class
- Oxytocin
- Defined daily dose
- 15 E, N
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
303 interactions on record for oxytocin.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxytocin · interactions on record
303 records
- 71 severe
- 228 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxytocin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomOxytocin 10units/1ml concentrate for solution for infusion ampoulesA A H Pharmaceuticals Ltd
- United StatesOxytocinFresenius Kabi USA, LLC
- SwedenOxygrindeks 8,3 mikrogram/ml Injektions-/infusionsvätska, lösningAS GRINDEKS
- NorwayOxytocin cd pharmaCD Pharmaceuticals
- FinlandOxytocin OrifarmOrifarm Generics A/S
- CzechiaOFOSTAS GRINDEKS, Riga
- NetherlandsOxytocine Eureco-Pharma 5 IE/ml, concentraat voor oplossing voor infusie, oplossing voor injectieEureco-Pharma B.V.
- IrelandOfost 10 IU/ml concentrate for solution for infusion or solution for intramuscular injectionAS Grindeks
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Oxytocin Grindeks, Syntocinon
- Belgium · Oxytocin Grindeks, Syntocinon
- Bulgaria · Окситоцин Pихtep
- Cyprus · Syntocinon
- Czechia · Ofost, Oxytocin Avmc
- Denmark · Oxytocin Orifarm, Syntocinon
- Estonia · Oxytocin Grindeks
- Spain · Oxitocina Grindeks, Syntocinon
- Finland · Oxytocin Orifarm, Syntocinon
- France · Oxytocine Ever Pharma, Oxytocine Grindeks
- United Kingdom (Northern Ireland) · Oxytocin, Oxytocin Hameln Pharma
- Greece · Oxytocin Gap
- Croatia · Syntocinon
- Hungary · Oxytocin Grindeks, Oxytocin Panpharma
- Ireland · Ofost, Oxytocin Pinewood Laboratories
- Iceland · Syntocinon
- Italy · Ossitocina Grindeks, Syntocinon
- Lithuania · Ofost, Oxytocin Grindeks
- Latvia · Ofost, Oxytocin Grindeks
- Malta · Oxytocin Wockhardt, Syntocinon
- Netherlands · Syntocinon
- Norway · Oxytocin Cd Pharma, Oxytocin Orifarm
- Poland · Oxytocin Grindeks, Oxytocin Grindex
- Portugal · Oxitocina Generis, Oxitocina Grindeks
- Romania · Ofost, Oxitocină Panpharma
- Sweden · Oxytocin Cd Pharma, Oxytocin Grindeks
- Slovenia · Ofost, Syntocinon
- Slovakia · Ofost, Oxygrindeks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c8629d6d-dcc0-4b61-84c6-5f246f8d6c5a GET /v1/drugs/c8629d6d-dcc0-4b61-84c6-5f246f8d6c5a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Oxytocin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about oxytocin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.